Drug details
Fetzima (levomilnacipran extended-release capsules)
type of Antidepressants, SNRIs
Fetzima (levomilnacipran) extended-release is a type of antidepressant called a serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat Major Depressive Disorder (MDD).
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- lightheadedness,
- confusion,
- dizziness,
- blurred vision,
- dry mouth,
- pounding in the ears,
- sweating,
- weakness,
- restlessness,
- chest pain or pressure,
- unusual tiredness,
- painful urination,
- little or no urination,
- anxiety,
- tremors,
- difficulty speaking,
- numbness or tingling,
- slow heartbeat,
- irritability
- fainting, and
- difficulty urinating,
- drooling,
- trouble sleeping (insomnia),
- loss of balance or coordination,
- fast, pounding, or irregular heartbeats,
- arm, back or jaw pain,
- muscle stiffness, trembling or jerking,
- painful urinating,
- rapid or irregular heartbeat,
- cloudy urine,
- difficulty passing urination (dribbling),
- uncontrolled muscle movements, especially of the face, neck and back,
The following drugs are related to Fetzima, either as a replacement or used together:
- Albuterol Sulfate Tablets (albuterol sulfate tablets)
- Zyban (bupropion hcl)
- Cymbalta (duloxetine hcl)
- Effexor (venlafaxine hydrochloride)
- Effexor XR (venlafaxine hydrochloride extended-release)
- Geodon (ziprasidone)
- Zyprexa Relprevv (olanzapine extended release injectable suspension)
- Trileptal (oxcarbazepine)
- Paxil (paroxetine hydrochloride)
- Paxil-CR (paroxetine hydrochloride)
- Pexeva (paroxetine mesylate)
- Seroquel XR (quetiapine fumarate extended-release tablets)
- Zoloft (sertraline hcl)